This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover ways to maximize earnings for debt repayment. Efficient strategies can lead to faster debt elimination.
19,968 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
Investors often ask if a name like AMD represents a stock generational buying opportunity. This guide breaks down the...
Two popular consumer sector ETFs sit at the crossroads of liquidity and diversification. XLY concentrates on large‑ca...
Nvidia and Broadcom sit at the heart of AI infrastructure. This guide breaks down which growth stock better fits diff...
As baby boomers turn caregiving, millions of families juggle medical bills and reduced wages. The shifting care econo...
As markets wobble and political headwinds rise, a growing chorus argues that ceos have forgotten moderate. This piece...
The iShares SOXX ETF has climbed 93.3% year-to-date through July 6, 2026, as AI infrastructure demand fuels gains acr...
Meta and Amazon are at the forefront of a trillion-dollar Big Tech capex surge, led by AI infrastructure and data-cen...
Settle in with a cup of coffee and a clear market view. This guide bundles 10 weekend reads that translate complex fi...
Herald Investment Management disclosed a new 202,000-share position in DigitalOcean Holdings (DOCN), valued at roughl...
Nvidia’s leadership signals a pivotal moment in AI. This guide breaks down what the agentic inflection point means fo...